Rhythm Pharmaceuticals Inc. Revenue 2016–2025
Rhythm Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rhythm Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 60.1 M, a 83.81% increase year-over-year.
- Rhythm Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 192.6 M, a 73.84% increase year-over-year.
- Rhythm Pharmaceuticals Inc. annual revenue for 2025 was 189.8 M, a 45.83% increase from 2024.
- Rhythm Pharmaceuticals Inc. annual revenue for 2024 was 130.1 M, a 68.06% increase from 2023.
- Rhythm Pharmaceuticals Inc. annual revenue for 2023 was 77.4 M, a 227.56% increase from 2022.
- Rhythm Pharmaceuticals Inc. annual revenue for 2022 was 23.6 M.
Rhythm Pharmaceuticals Inc. (RYTM) — Frequently Asked Questions
Rhythm Pharmaceuticals Inc. (RYTM) is a publicly traded US company. It has a market capitalization of $5.57B. In fiscal 2025 it reported revenue of $190M and net income of -$197M. Explore RYTM's stock price, financial statements, earnings history, margins and key ratios below.
What is Rhythm Pharmaceuticals Inc.'s market cap?
Rhythm Pharmaceuticals Inc. (RYTM) has a market capitalization of $5.57B.
What is the RYTM stock price?
RYTM trades at $85.71 (-2.45% on the day).
How much revenue does Rhythm Pharmaceuticals Inc. make?
Rhythm Pharmaceuticals Inc. reported revenue of $190M in fiscal 2025.
Is RYTM profitable?
In fiscal 2025, Rhythm Pharmaceuticals Inc. reported net income of -$197M.